Kenya Confirms Third Ebola Case as Screening Measures Expand

2026-10-17 services

Nairobi, 17 October 2026
Kenya has confirmed a third Ebola case in a quarantined relative of previous patients, as health officials intensify border screening to prevent wider community transmission.

Containment Protocols and New Domestic Cases

Following the initial identification of Kenya’s first confirmed Ebola death involving a traveller who arrived from the Democratic Republic of the Congo (DRC) earlier this month [1][11], public health authorities have confirmed a third case of the virus within national borders [2][3]. The patient, a 65-year-old woman, is a close relative and primary contact of the country’s first two confirmed cases [2][9]. Health officials verified that she tested positive while already completing a 10-day quarantine prior to developing symptoms [2][8][12]. This update follows the diagnosis of Kenya’s second case on 14 October 2026, which involved a 39-year-old male relative who exhibited fever, fatigue, and joint pain while isolated [10][13]. Director-General for Health Patrick Amoth confirmed that the woman is currently receiving supportive care, leaving two patients under active medical supervision following the earlier death of the index case [2][8][12].

Surveillance Expansion and Contact Tracing

Despite the confirmation of a third infection, health officials emphasize that there is no evidence of community transmission and maintain that the overall public health risk remains low [8][11]. Containment measures have nevertheless been significantly heightened across key transit hubs, including Jomo Kenyatta International Airport in Nairobi, where active monitoring protocols have been operational since early October [8][10][14]. Public health teams have traced 127 contacts associated with the initial cluster, placing 94 individuals under mandatory quarantine [8][13]. Furthermore, health border posts have screened more than 685,000 travellers, supported by five designated diagnostic laboratories nationwide to ensure rapid sample processing [8][13].

Regional Impact and Vaccine Development

Kenya’s domestic health response takes place against an escalating regional epidemic in the DRC, where the outbreak recently spread to an eighth province, North Ubangi [2][4]. Data from the US Centers for Disease Control and Prevention (CDC) indicates that the epidemic has accumulated 9,235 cumulative cases and 4,444 deaths [2]. This establishes a case fatality rate of 48.121% across affected regions [2]. The burden on younger demographics has been particularly severe; 10 students in the DRC have died from the Bundibugyo Ebola strain within weeks of schools reopening, contributing to a total of 961 child fatalities since May 2026 [2][5][6]. Because no specific treatment exists for the Bundibugyo strain, clinical researchers in Uganda have initiated a Phase 1 trial for a novel candidate vaccine to evaluate safety and immune response mechanisms [2][7].

Bronnen

Ebola outbreak Health ministry